Skip to main
CJC-1295 Compound

An ink-and-paper field guide to the GHRH analog CJC-1295 — with-DAC, no-DAC, and the ipamorelin stack, drawn from the literature.

About CJC-1295 Compound: Studies for Your Questions

Reading the Studies Can Help You Prepare Health Questions

Still experimental, CJC-1295 prompts the release of growth-related hormones. Here you'll learn what this information can offer before a conversation with your doctor.

You can read published findings and follow numbered links to the papers behind the figures. This site explains studies; it doesn't offer appointments, prescriptions, products, or pharmacy services.

Your doctor can consider your health, other medicines, and reasons for asking about CJC-1295. A study can't make that choice or account for your medical history.

The word compound means the substance studied, rather than a service that mixes medicines. If you're seeking care, that conversation belongs with your doctor.

Teichman 2006 and Ionescu 2006 involved 24 healthy adults altogether. Their longest follow-up was 49 days, leaving the risks of longer use unknown.

Jetté 2005 tested rats, while other animal work examined growth and ipamorelin, a separate growth hormone releasing compound. The FDA's 2024 review raised safety concerns about medicines pharmacies mix from CJC-1295.

The shorter-lasting form lacks published human measurements of its time in blood. Neither form has long human safety testing you can rely on.

I'd ask what a proposed treatment is meant to help you do each day. You can then ask who was studied, how long people were followed, and how your doctor would judge whether a change in blood tests had actually helped you in your daily life.

Animal Findings Can’t Establish the Same Benefit for You

A CJC-1295 health claim needs more than an explanation of how the compound works. Tests with animals, or with cells in dishes, don't establish the same result in people.

Even human testing may measure hormone levels without measuring how anyone feels. You can ask whether the study measured a change that matters to your concern.

Questions about treatment amounts and safe use need your doctor's attention. Study results don't show how the compound would mix with your medicines or give you a prescription.

The site has no endorsement from medical, scientific, or government bodies. The presence of studies doesn't mean those bodies have approved a treatment.

If you hear a confident claim, ask whether people were actually tested. Ask whether their age, health, and reason for treatment resemble yours.

Pharmacy Review Left the Compound Without FDA Approval

The FDA hasn't approved CJC-1295 as a medicine for people. Its December 2024 pharmacy panel considered medicines mixed from CJC-1295 and raised concerns about immune system reactions [16].

WADA, which sets banned drug rules in sport, prohibits CJC-1295 under its 2024 rules. Reviewing CJC-1295 research can help your questions, but doesn't establish that CJC-1295 use would be safe.